Skip to content

A `perfect storm` of HIV and multidrug-resistant TB building, experts warn

BHIVA issues draft guidelines on HIV and cancer

Return of nelfinavir's European license recommended

ICAAC: Incidence of non-AIDS-defining cancers remains higher for HIV-positive individuals despite HAART

ICAAC: Gardasil provides some protection against wide spectrum of cancer-causing HPV

ICAAC: Moxifloxacin could cut TB treatment time to four months

US guidance says that pregnant women should not take nelfinavir

WHO to monitor ARV side-effects worldwide

Nelfinavir shows promise as a cancer therapy